MEASLES & RUBELLA STRATEGIC FRAMEWORK 2021-2030

The Measles & Rubella Partnership supports implementation of the Measles & Rubella Strategic Framework 2021-2030

The measles and rubella strategic framework 2021-2030 (MRSF 2021-2030) aims to provide a high-level framework that will guide the development of regional and national strategies and operational plans. The MRSF 2021-2030 was developed through a broad consultative process to obtain feedback on achievements and major short falls of the past decade, and to define the strategic pivots and focus areas for the next decade. It will serve as a disease-specific strategy within the umbrella of the Immunization Agenda 2030 (IA2030) structure and is in alignment with other key agency strategy documents, including the 13th WHO General Programme of Work 2019-23 (GPW13), the UNICEF Immunization Roadmap 2018-2030 and the Gavi Alliance 2021-2025 strategy (Gavi 5.0).

The Measles and Rubella Strategic Framework 2021-2030 envisions “A world free from measles and rubella”.

The goal for the 2021-2030 period is to “achieve and sustain the regional measles and rubella elimination goals”.

The MRSF 2021-2030 adopts the structure of IA2030, including its strategic priorities, describing the measles and rubella-specific objectives under each strategic priority along with the focus areas for achieving the objectives. It also describes how the core principles of IA2030 will be applied to each of the priority and focus areas within the context of measles and rubella elimination. The objective of this framework is to guide all stakeholders at country, regional, and global levels to plan and implement more effective measles and rubella elimination and control activities and to raise the ambition level towards achieving a world without measles and rubella.

Download PDF

Updated on February 23, 2021

Partnership Alliance

The mark 'CDC' is owned by the US Dept. of Health and Human Services and is used with permission. Use of this logo is not an endorsement by HHS or CDC of any particular product, service, or enterprise. CDC's logo and work with the Partnership is not connected to any fundraising aspect of the organization.